CoChat

Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study

Open access
Martinelli, Nicola, Traglia, Michela, Campostrini, Natascia, Biino, Ginevra, Corbella, Michela, Sala, Cinzia, Busti, Fabiana, Masciullo, Corrado, Manna, Daniele, Previtali, Sara, Castagna, Annalisa, Pistis, Giorgio, Olivieri, Oliviero, Toniolo, Daniela, Camaschella, Clara, Girelli, Domenico · 2012 · PLoS ONE
Cited by 92

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The recent discovery of hepcidin, the key iron regulatory hormone, has changed our view of iron metabolism, which in turn is long known to be linked with insulin resistant states, including type 2 diabetes mellitus and the Metabolic Syndrome (MetS). Serum ferritin levels are often elevated in MetS (Dysmetabolic hyperferritinemia--DHF), and are sometimes associated with a true mild-to-moderate hepatic iron overload (dysmetabolic iron overload syndrome--DIOS). However, the pathophysiological link between iron and MetS remains unclear. This study was aimed to investigate, for the first time, the relationship between MetS and hepcidin at population level. We measured serum hepcidin levels by Mass Spectrometry in 1,391 subjects from the Val Borbera population, and evaluated their relationship with classical MetS features. Hepcidin levels increased significantly and linearly with increasing number of MetS features, paralleling the trend of serum ferritin. In multivariate models adjusted for relevant variables including age, C-Reactive Protein, and the HFE C282Y mutation, ferritin was the only significant independent predictor of hepcidin in males, while in females MetS was also independently associated with hepcidin. Overall, these data indicate that the fundamental iron regulatory feedback is preserved in MetS, i.e. that hepcidin tends to progressively increase in response to the increase of iron stores. Due to recently discovered pleiotropic effects of hepcidin, this may worsen insulin resistance and contribute to the cardiovascular complications of MetS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0048250

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 92

Metadata

Authors
Martinelli, N., Traglia, M., Campostrini, N., Biino, G., Corbella, M., Sala, C., Busti, F., Masciullo, C., Manna, D., Previtali, S., Castagna, A., Pistis, G., Olivieri, O., Toniolo, D., Camaschella, C., & Girelli, D.
Venue
PLoS ONE
Published
2012-10-29
Volume
7
Issue
10
Pages
e48250
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1971039138
Cited by
92
References
15
FWCI
5.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study. https://app.cochat.ai/papers/10.1371/journal.pone.0048250
The paper
Martinelli, N., Traglia, M., Campostrini, N., Biino, G., Corbella, M., Sala, C., Busti, F., Masciullo, C., Manna, D., Previtali, S., Castagna, A., Pistis, G., Olivieri, O., Toniolo, D., Camaschella, C., & Girelli, D. (2012). Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study. PLoS ONE. https://doi.org/10.1371/journal.pone.0048250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.